PURPOSE: When performing coronary artery bypass grafting, anastomotic insufficiency needs to be detected during surgery. We developed a novel indocyanine green angiography system, the HyperEye Medical System (HEMS), which enables color imaging of the bypass flow. This article described the accuracy of HEMS angiography for predicting graft patency. METHODS: A total of 144 grafts in 40 coronary artery bypass grafting patients were assessed by HEMS angiography, a transit time flowmeter (TTF) during surgery and fluoroscopic angiography 1 year after the operation. RESULTS: HEMS angiography showed normal flow in 133 grafts, but abnormal flow in 11. Fluoroscopic angiography showed that 130 of the 133 "normal" grafts were patent (negative predictive value: 97.7%) and that nine of the 11 "abnormal" grafts were occluded (positive predictive value: 81.8%). As a result, 134 grafts were assessed as normal and 10 as abnormal by TTF. Fluoroscopic angiography showed that 124 of these 134 grafts were patent (negative predictive value: 92.5%), whereas two of the 10 grafts were occluded (positive predictive value: 20.0%). For the 127 grafts with compatible results by the HEMS and TTF assessments, the positive and negative predictive values were 100 and 97.6%, respectively. CONCLUSION: HEMS angiography of a bypass graft may provide an accurate prediction of the graft patency after surgery.
PURPOSE: When performing coronary artery bypass grafting, anastomotic insufficiency needs to be detected during surgery. We developed a novel indocyanine green angiography system, the HyperEye Medical System (HEMS), which enables color imaging of the bypass flow. This article described the accuracy of HEMS angiography for predicting graft patency. METHODS: A total of 144 grafts in 40 coronary artery bypass grafting patients were assessed by HEMS angiography, a transit time flowmeter (TTF) during surgery and fluoroscopic angiography 1 year after the operation. RESULTS:HEMS angiography showed normal flow in 133 grafts, but abnormal flow in 11. Fluoroscopic angiography showed that 130 of the 133 "normal" grafts were patent (negative predictive value: 97.7%) and that nine of the 11 "abnormal" grafts were occluded (positive predictive value: 81.8%). As a result, 134 grafts were assessed as normal and 10 as abnormal by TTF. Fluoroscopic angiography showed that 124 of these 134 grafts were patent (negative predictive value: 92.5%), whereas two of the 10 grafts were occluded (positive predictive value: 20.0%). For the 127 grafts with compatible results by the HEMS and TTF assessments, the positive and negative predictive values were 100 and 97.6%, respectively. CONCLUSION:HEMS angiography of a bypass graft may provide an accurate prediction of the graft patency after surgery.
Authors: Nimesh D Desai; Senri Miwa; David Kodama; Taadaki Koyama; Gideon Cohen; Marc P Pelletier; Eric A Cohen; George T Christakis; Bernard S Goldman; Stephen E Fremes Journal: J Thorac Cardiovasc Surg Date: 2006-07-28 Impact factor: 5.209
Authors: David P Taggart; Bikram Choudhary; Kyriakos Anastasiadis; Yasir Abu-Omar; Lognathen Balacumaraswami; David W Pigott Journal: Ann Thorac Surg Date: 2003-03 Impact factor: 4.330
Authors: Christian Detter; Detlef Russ; Andre Iffland; Sabine Wipper; Marc O Schurr; Herman Reichenspurner; Gerd Buess; Bruno Reichart Journal: Heart Surg Forum Date: 2002 Impact factor: 0.676
Authors: D D McPherson; L F Hiratzka; W C Lamberth; B Brandt; M Hunt; R A Kieso; M L Marcus; R E Kerber Journal: N Engl J Med Date: 1987-02-05 Impact factor: 91.245
Authors: Natasha E Khan; Anthony De Souza; Rebecca Mister; Marcus Flather; Jonathan Clague; Simon Davies; Peter Collins; Duolao Wang; Ulrich Sigwart; John Pepper Journal: N Engl J Med Date: 2004-01-01 Impact factor: 91.245
Authors: Christian Detter; Sabine Wipper; Detlef Russ; Andre Iffland; Lars Burdorf; Eckart Thein; Karl Wegscheider; Hermann Reichenspurner; Bruno Reichart Journal: Circulation Date: 2007-08-07 Impact factor: 29.690